Skip to main content

Advertisement

Table 1 Clinical characteristics and expression of AIM2 between CHB group and CHC group

From: Expression of AIM2 is correlated with increased inflammation in chronic hepatitis B patients

  CHB CHC P value
n = 47 n = 23
Age (y) 38.2 ± 9.0 37.8 ± 9.6 0.750
Male, n (%) 30(63.8) 14(60.9) 0.810
ALT (IU/L) 64.1 ± 40.0 55.5 ± 31.9 0.292
AST (IU/L) 63.8 ± 25.0 58.4 ± 37.7 0.241
TB (μmol/mL) 18.6 ± 7.7 26.7 ± 9.7 0.240
ALB (g/L) 38.6 ± 11.9 39.8 ± 6.2 0.165
PTA (%) 85.7 ± 10.9 86.3 ± 12.4 0.722
WBC (109/L) 6.4 ± 1.8 6.6 ± 2.0 0.381
PLT (109/L) 137.7 ± 51.7 176.3 ± 55.6 0.366
AIM2, n (%) 42(89.4) 2 (8.7) 0.000
  1. AIM2 absent in melanoma, CHB chronic hepatitis B, CHC chronic hepatitis C, ALT alanine transaminase, AST aspartate aminotransferase, TB total Bilirubin, ALB albumin, PTA prothrombin activity, WBC white blood cell, PLT platelet